302 related articles for article (PubMed ID: 7962285)
41. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases.
Hubalewska-Hola A; Fröss K; Kostecka-Matyja M; Sowa-Staszczak A; Szybiński Z; Huszno B; Ptak M
Przegl Lek; 2003; 60(11):768-71. PubMed ID: 15058054
[TBL] [Abstract][Full Text] [Related]
42. [Acromegaly associated with McCune-Albright syndrome].
Tóth M; Töke J; Kiss E; Bernád I; Miheller P; Szücs N; Rácz K
Orv Hetil; 2002 May; 143(19 Suppl):1070-3. PubMed ID: 12063863
[TBL] [Abstract][Full Text] [Related]
43. Autonomous growth hormone secretion due to McCune Albright syndrome in paediatric age group: an ominous triad.
Jayant SS; Walia R; Gupta R; Pal R; Chaudhary S; Agrawal K; Rastogi A; Bhattacharya A; Dutta P; Bhadada SK; Bhansali A
Endocrine; 2023 Jul; 81(1):149-159. PubMed ID: 36877453
[TBL] [Abstract][Full Text] [Related]
44. A case of thyrotropin-secreting pituitary macroadenoma.
Sunthornthepvarakul T; Prachasilchai P; Komindr A; Ngowngarmratana S; Dansirikul R
J Med Assoc Thai; 2001 Jun; 84(6):897-906. PubMed ID: 11556473
[TBL] [Abstract][Full Text] [Related]
45. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations.
Collins MT; Sarlis NJ; Merino MJ; Monroe J; Crawford SE; Krakoff JA; Guthrie LC; Bonat S; Robey PG; Shenker A
J Clin Endocrinol Metab; 2003 Sep; 88(9):4413-7. PubMed ID: 12970318
[TBL] [Abstract][Full Text] [Related]
46. [A case of fibrous dysplasia (McCune Albright syndrome) associated with acromegaly].
Chiba Y; Tani N; Tamura N; Nakamura H; Igarashi K; Momotsu T; Tsuda A; Ito S; Shibata A; Tamura T
Nihon Naibunpi Gakkai Zasshi; 1991 Mar; 67(3):239-48. PubMed ID: 2070893
[TBL] [Abstract][Full Text] [Related]
47. Clinical, endocrinological and radiography features in a child with McCune-Albright syndrome and pituitary adenoma.
Zumkeller W; Jassoy A; Lebek S; Nagel M
J Pediatr Endocrinol Metab; 2001 May; 14(5):553-9. PubMed ID: 11393578
[TBL] [Abstract][Full Text] [Related]
48. Ectopic Suprasellar Thyrotropin-Secreting Pituitary Adenoma: Case Report and Literature Review.
Wang Q; Lu XJ; Sun J; Wang J; Huang CY; Wu ZF
World Neurosurg; 2016 Nov; 95():617.e13-617.e18. PubMed ID: 27567574
[TBL] [Abstract][Full Text] [Related]
49. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome.
Vortmeyer AO; Gläsker S; Mehta GU; Abu-Asab MS; Smith JH; Zhuang Z; Collins MT; Oldfield EH
J Clin Endocrinol Metab; 2012 Jul; 97(7):2404-13. PubMed ID: 22564667
[TBL] [Abstract][Full Text] [Related]
50. Mammosomatotroph adenoma causing gigantism in an 8-year old boy: a possible pathogenetic mechanism.
Dubuis JM; Deal CL; Drews RT; Goodyer CG; Lagacé G; Asa SL; Van Vliet G; Collu R
Clin Endocrinol (Oxf); 1995 May; 42(5):539-49. PubMed ID: 7621575
[TBL] [Abstract][Full Text] [Related]
51. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
Zimmerman D; Young WF; Ebersold MJ; Scheithauer BW; Kovacs K; Horvath E; Whitaker MD; Eberhardt NL; Downs TR; Frohman LA
J Clin Endocrinol Metab; 1993 Jan; 76(1):216-22. PubMed ID: 8421089
[TBL] [Abstract][Full Text] [Related]
52. Unusual phenotypical variations in a boy with McCune-Albright syndrome.
Mamkin I; Philibert P; Anhalt H; Ten S; Sultan C
Horm Res Paediatr; 2010; 73(3):215-22. PubMed ID: 20197676
[TBL] [Abstract][Full Text] [Related]
53. G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome.
Weinstein LS
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P120-4. PubMed ID: 17229000
[TBL] [Abstract][Full Text] [Related]
54. Treatment protocols for growth hormone-secreting pituitary adenomas combined with craniofacial fibrous dysplasia: A case report of atypical McCune-Albright syndrome.
Xu J; Li X; Lv CS; Chen Y; Wang M; Liu JF; Gui L
Exp Ther Med; 2014 Sep; 8(3):877-880. PubMed ID: 25120617
[TBL] [Abstract][Full Text] [Related]
55. Gigantism with pituitary macroadenoma: an unusual variant of McCune-Albright syndrome.
Queirolo S; Gallarotti F; Capuano E; Garrè ML; Spaziante R; Di Battista E
J Pediatr Endocrinol Metab; 2009 Feb; 22(2):177-9. PubMed ID: 19449675
[No Abstract] [Full Text] [Related]
56. TSH-secreting pituitary macroadenoma: rapid tumor shrinkage and recovery from hyperthyroidism with octreotide.
Fischler MP; Reinhart WH
J Endocrinol Invest; 1999 Jan; 22(1):64-5. PubMed ID: 10090139
[TBL] [Abstract][Full Text] [Related]
57. Clinical and immunohistochemical studies on TSH-secreting pituitary adenoma: its multihormonality and expression of Pit-1.
Sanno N; Teramoto A; Matsuno A; Inada K; Itoh J; Osamura RY
Mod Pathol; 1994 Dec; 7(9):893-9. PubMed ID: 7892156
[TBL] [Abstract][Full Text] [Related]
58. Early fractures and occult hyperthyroidism: McCune-Albright syndrome?
Di Candia S; Weber G; Mora S; de Pellegrin M; Chiumello G
Horm Res; 2001; 56(1-2):58-62. PubMed ID: 11815729
[TBL] [Abstract][Full Text] [Related]
59. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract][Full Text] [Related]
60. McCune-Albright syndrome: molecular genetics.
Lumbroso S; Paris F; Sultan C
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():875-82. PubMed ID: 12199345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
